Enhancing adherence and completion of the three-month isoniazid with rifapentine (3HP) tuberculosis preventive therapy regimen through biomarker-guided adherence counselling

Related Resources

• Search and filter all Fogarty grants
• About Fogarty's programs
• Search all NIH grants and grantees using NIH RePORTER

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Emerging Global Leader

Project Information in NIH RePORTER

Enhancing adherence and completion of the three-month isoniazid with rifapentine (3HP) tuberculosis preventive therapy regimen through biomarker-guided adherence counselling

Principal Institution

Kenyatta National Hospital

Principal Investigator(s) (PI)

Onyango, Dickens Otieno

Project Contact Information

Email: macdickens2002@gmail.com

Year(s) Awarded

2025-2030

Country

Kenya

Related World Regions / Countries

• Sub-Saharan Africa

Related Global Health Research Topics

• Tuberculosis